<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33661429</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-4919</ISSN><JournalIssue CitedMedium="Internet"><Volume>476</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Molecular and cellular biochemistry</Title><ISOAbbreviation>Mol Cell Biochem</ISOAbbreviation></Journal><ArticleTitle>Evidence of synergism among three genetic variants in a patient with LMNA-related lipodystrophy and amyotrophic lateral sclerosis leading to a remarkable nuclear phenotype.</ArticleTitle><Pagination><StartPage>2633</StartPage><EndPage>2650</EndPage><MedlinePgn>2633-2650</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11010-021-04103-7</ELocationID><Abstract><AbstractText>Neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), can be clinically heterogeneous which may be explained by the co-inheritance of multiple genetic variants that modify the clinical course. In this study we examine variants in three genes in a family with one individual presenting with ALS and lipodystrophy. Sequencing revealed a p.Gly602Ser variant in LMNA, and two additional variants, one each in SETX (g.intron10-13delCTT) and FUS (p.Gly167_Gly168del). These latter genes have been linked to ALS. All family members were genotyped and each variant, and each combination of variants detected, were functionally evaluated in vitro regarding effects on cell survival, expression patterns and cellular phenotype. Muscle biopsy retrieved from the individual with ALS showed leakage of chromatin from the nucleus, a phenotype that was recapitulated in vitro with expression of all three variants simultaneously. Individually expressed variants gave cellular phenotypes there were unremarkable. Interestingly the FUS variant appears to be protective against the effects of the SETX and the LMNA variants on cell viability and may indicate loss of interaction of FUS with SETX and/or R-loops. We conclude that these findings support genetic modifications as an explanation of the clinical heterogeneity observed in human disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Volkening</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-7601-4869</Identifier><AffiliationInfo><Affiliation>Molecular Medicine, Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farhan</LastName><ForeName>Sali M K</ForeName><Initials>SMK</Initials><Identifier Source="ORCID">0000-0001-5936-0957</Identifier><AffiliationInfo><Affiliation>Analytic and Translational Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kao</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Molecular Medicine, Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leystra-Lantz</LastName><ForeName>Cheryl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Molecular Medicine, Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ang</LastName><ForeName>Lee Cyn</ForeName><Initials>LC</Initials><Identifier Source="ORCID">0000-0003-0940-4995</Identifier><AffiliationInfo><Affiliation>Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, London Health Sciences Centre-University Hospital, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIntyre</LastName><ForeName>Adam</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7836-5187</Identifier><AffiliationInfo><Affiliation>Blackburn Cardiovascular Genetics Lab, Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Blackburn Cardiovascular Genetics Lab, Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hegele</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><Identifier Source="ORCID">0000-0003-2861-5325</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, London Health Sciences Centre-University Hospital, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Blackburn Cardiovascular Genetics Lab, Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strong</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0003-1988-6262</Identifier><AffiliationInfo><Affiliation>Molecular Medicine, Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada. mstrong@uwo.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada. mstrong@uwo.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mol Cell Biochem</MedlineTA><NlmUniqueID>0364456</NlmUniqueID><ISSNLinking>0300-8177</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494847">LMNA protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034904">Lamin Type A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064251">Multifunctional Enzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C484368">SETX protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.-</RegistryNumber><NameOfSubstance UI="D004265">DNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D020365">RNA Helicases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004265" MajorTopicYN="Y">DNA Helicases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034904" MajorTopicYN="Y">Lamin Type A</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008060" MajorTopicYN="Y">Lipodystrophy</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064251" MajorTopicYN="Y">Multifunctional Enzymes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="Y">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020365" MajorTopicYN="Y">RNA Helicases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="Y">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Fused in sarcoma (FUS)</Keyword><Keyword MajorTopicYN="N">Lamin A (LMNA)</Keyword><Keyword MajorTopicYN="N">Nuclear membrane</Keyword><Keyword MajorTopicYN="N">R-loop</Keyword><Keyword MajorTopicYN="N">Senataxin (SETX)</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>4</Day><Hour>12</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33661429</ArticleId><ArticleId IdType="pmc">PMC8192393</ArticleId><ArticleId IdType="doi">10.1007/s11010-021-04103-7</ArticleId><ArticleId IdType="pii">10.1007/s11010-021-04103-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Farhan SMK, Gendron TF, Petrucelli L, Hegele RA, Strong MJ. OPTN p.Met468Arg and ATXN2 intermediate length polyQ extension in families with C9orf72 mediated amyotrophic lateral sclerosis and frontotemporal dementia. Am J Med Genet B. 2018;177:75&#x2013;85. doi: 10.1002/ajmg.b.32606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.b.32606</ArticleId><ArticleId IdType="pubmed">29080331</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhan SMK, Gendron TF, Petrucelli L, Hegele RA, Strong MJ. ARHGEF28 p.Lys280Metfs40Ter in an amyotrophic lateral sclerosis family with a C9orf72 expansion. Neurol Genet. 2017;3:e190. doi: 10.1212/NXG.0000000000000190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000190</ArticleId><ArticleId IdType="pmc">PMC5616022</ArticleId><ArticleId IdType="pubmed">28971145</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Kwong LK, Sampathu DM, Trojanowski JQ, Lee VM. TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. Arch Neurol. 2007;64:1388&#x2013;1394. doi: 10.1001/archneur.64.10.1388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.64.10.1388</ArticleId><ArticleId IdType="pubmed">17923623</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder V, Gregory JM, Barria MA, Green A, Pal S. TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis. BMC Neurol. 2018;18:90. doi: 10.1186/s12883-018-1091-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-018-1091-7</ArticleId><ArticleId IdType="pmc">PMC6027783</ArticleId><ArticleId IdType="pubmed">29954341</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, Ganesalingam J, Williams KL, Tripathi V, Al-Saraj S, Al-Chalabi A, Leigh PN, Blair IP, Nicholson G, de Belleroche J, Gallo JM, Miller CC, Shaw CE. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, Valdmanis P, Rouleau GA, Hosler BA, Cortelli P, de Jong PJ, Yoshinaga Y, Haines JL, Pericak-Vance MA, Yan J, Ticozzi N, Siddique T, McKenna-Yasek D, Sapp PC, Horvitz HR, Landers JE, Brown RH., Jr Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Picher-Martel V, Brunet F, Dupre N, Chrestian N. The occurrence of FUS mutations in pediatric amyotrophic lateral sclerosis: a case report and review of the literature. J Child Neurol. 2020;35:556&#x2013;562. doi: 10.1177/0883073820915099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0883073820915099</ArticleId><ArticleId IdType="pubmed">32281455</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Liu MS, Li XG, Cui LY. Mutations in FUS are the most frequent genetic cause in juvenile sporadic ALS patients of Chinese origin. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:249&#x2013;252. doi: 10.3109/21678421.2016.1143012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1143012</ArticleId><ArticleId IdType="pubmed">26972116</ArticleId></ArticleIdList></Reference><Reference><Citation>Droppelmann CA, Keller BA, Campos-Melo D, Volkening K, Strong MJ. Rho guanine nucleotide exchange factor is an NFL mRNA destabilizing factor that forms cytoplasmic inclusions in amyotrophic lateral sclerosis. Neurobiol Aging. 2013;34:248&#x2013;262. doi: 10.1016/j.neurobiolaging.2012.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.06.021</ArticleId><ArticleId IdType="pubmed">22835604</ArticleId></ArticleIdList></Reference><Reference><Citation>Droppelmann CA, Wang J, Campos-Melo D, Keller B, Volkening K, Hegele RA, Strong MJ. Detection of a novel frameshift mutation and regions with homozygosis within ARHGEF28 gene in familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:444&#x2013;451. doi: 10.3109/21678421.2012.758288.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2012.758288</ArticleId><ArticleId IdType="pubmed">23286752</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkening K, Leystra-Lantz C, Strong MJ. Human low molecular weight neurofilament (NFL) mRNA interacts with a predicted p190RhoGEF homologue (RGNEF) in humans. Amyotroph Lateral Scler. 2010;11:97&#x2013;103. doi: 10.3109/17482960902995584.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902995584</ArticleId><ArticleId IdType="pubmed">19488899</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Tang L, Chen L, Zhang B, Deng P, Wang J, Yang Y, Liu R, Yang Y, Ye S, Liu X, Zhang H, Fan D. ARHGEF28 gene exon 6/intron 6 junction mutations in Chinese amyotrophic lateral sclerosis cohort. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:309&#x2013;311. doi: 10.3109/21678421.2014.896926.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.896926</ArticleId><ArticleId IdType="pubmed">24712971</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O&#x2019;Regan JP, Deng HX. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/364362c0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/364362c0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Liu MS, Li XG, Cui LY. Mutations in SOD1 and FUS caused juvenile-onset sporadic amyotrophic lateral sclerosis with aggressive progression. Ann Transl Med. 2015;3:221. doi: 10.3978/j.issn.2305-5839.2015.09.04.</Citation><ArticleIdList><ArticleId IdType="doi">10.3978/j.issn.2305-5839.2015.09.04</ArticleId><ArticleId IdType="pmc">PMC4583590</ArticleId><ArticleId IdType="pubmed">26488017</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano M, Quinzii CM, Mitsumoto H, Hays AP, Roberts JK, Richard P, Rowland LP. Senataxin mutations and amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:223&#x2013;227. doi: 10.3109/17482968.2010.545952.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.545952</ArticleId><ArticleId IdType="pmc">PMC7528023</ArticleId><ArticleId IdType="pubmed">21190393</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YZ, Bennett CL, Huynh HM, Blair IP, Puls I, Irobi J, Dierick I, Abel A, Kennerson ML, Rabin BA, Nicholson GA, Auer-Grumbach M, Wagner K, De JP, Griffin JW, Fischbeck KH, Timmerman V, Cornblath DR, Chance PF. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4) Am J Hum Genet. 2004;74:1128&#x2013;1135. doi: 10.1086/421054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/421054</ArticleId><ArticleId IdType="pmc">PMC1182077</ArticleId><ArticleId IdType="pubmed">15106121</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YZ, Hashemi SH, Anderson SK, Huang Y, Moreira MC, Lynch DR, Glass IA, Chance PF, Bennett CL. Senataxin, the yeast Sen1p orthologue: characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease. Neurobiol Dis. 2006;23:97&#x2013;108. doi: 10.1016/j.nbd.2006.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2006.02.007</ArticleId><ArticleId IdType="pubmed">16644229</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ. The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS) J Neurol Sci. 2010;288:1&#x2013;12. doi: 10.1016/j.jns.2009.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2009.09.029</ArticleId><ArticleId IdType="pubmed">19840884</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Volkening K. TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis? FEBS J. 2011;278:3569&#x2013;3577. doi: 10.1111/j.1742-4658.2011.08277.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2011.08277.x</ArticleId><ArticleId IdType="pubmed">21810174</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Kim JR, van Bruggen R, Park J. RNA-binding proteins in amyotrophic lateral sclerosis. Mol Cells. 2018;41:818&#x2013;829. doi: 10.14348/molcells.2018.0243.</Citation><ArticleIdList><ArticleId IdType="doi">10.14348/molcells.2018.0243</ArticleId><ArticleId IdType="pmc">PMC6182225</ArticleId><ArticleId IdType="pubmed">30157547</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard V, Minnerop M, Burk K, Kreuz F, Gillessen-Kaesbach G, Zuhlke C. Exon deletions and intragenic insertions are not rare in ataxia with oculomotor apraxia 2. BMC Med Genet. 2009;10:87. doi: 10.1186/1471-2350-10-87.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2350-10-87</ArticleId><ArticleId IdType="pmc">PMC2749023</ArticleId><ArticleId IdType="pubmed">19744353</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolaou P, Georghiou A, Votsi C, Middleton LT, Zamba-Papanicolaou E, Christodoulou K. A novel c.5308_5311delGAGA mutation in Senataxin in a Cypriot family with an autosomal recessive cerebellar ataxia. BMC Med Genet. 2008;9:28. doi: 10.1186/1471-2350-9-28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2350-9-28</ArticleId><ArticleId IdType="pmc">PMC2330029</ArticleId><ArticleId IdType="pubmed">18405395</ArticleId></ArticleIdList></Reference><Reference><Citation>Schols L, Arning L, Schule R, Epplen JT, Timmann D. &#x201c;Pseudodominant inheritance&#x201d; of ataxia with ocular apraxia type 2 (AOA2) J Neurol. 2008;255:495&#x2013;501. doi: 10.1007/s00415-008-0707-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-008-0707-z</ArticleId><ArticleId IdType="pubmed">18350359</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripolszki K, Torok D, Goudenege D, Farkas K, Sulak A, Torok N, Engelhardt JI, Klivenyi P, Procaccio V, Nagy N, Szell M. High-throughput sequencing revealed a novel SETX mutation in a Hungarian patient with amyotrophic lateral sclerosis. Brain Behav. 2017;7:e00669. doi: 10.1002/brb3.669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.669</ArticleId><ArticleId IdType="pmc">PMC5390843</ArticleId><ArticleId IdType="pubmed">28413711</ArticleId></ArticleIdList></Reference><Reference><Citation>Elert-Dobkowska E, Stepniak I, Krysa W, Ziora-Jakutowicz K, Rakowicz M, Sobanska A, Pilch J, Antczak-Marach D, Zaremba J, Sulek A. Next-generation sequencing study reveals the broader variant spectrum of hereditary spastic paraplegia and related phenotypes. Neurogenetics. 2019;20:27&#x2013;38. doi: 10.1007/s10048-019-00565-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-019-00565-6</ArticleId><ArticleId IdType="pmc">PMC6411833</ArticleId><ArticleId IdType="pubmed">30778698</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett CL, La Spada AR. Senataxin, a novel helicase at the interface of RNA transcriptome regulation and neurobiology: from normal function to pathological roles in motor neuron disease and cerebellar degeneration. Adv Neurobiol. 2018;20:265&#x2013;281. doi: 10.1007/978-3-319-89689-2_10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-89689-2_10</ArticleId><ArticleId IdType="pubmed">29916023</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C, Wang IX, Watts JA, Burdick JT, Guber RD, Zhu Z, Bruzel A, Lanman T, Chen K, Schindler AB, Edwards N, Ray-Chaudhury A, Yao J, Lehky T, Piszczek G, Crain B, Fischbeck KH, Cheung VG. Senataxin mutation reveals how R-loops promote transcription by blocking DNA methylation at gene promoters. Mol Cell. 2018;69:426&#x2013;437. doi: 10.1016/j.molcel.2017.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.12.030</ArticleId><ArticleId IdType="pmc">PMC5815878</ArticleId><ArticleId IdType="pubmed">29395064</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C, Patankar A, Amaya J, Watts JA, Li D, Ramirez P, Schindler AB, Fischbeck KH, Cheung VG. Clinical and molecular aspects of senataxin mutations in amyotrophic lateral sclerosis 4. Ann Neurol. 2020;87:547&#x2013;555. doi: 10.1002/ana.25681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25681</ArticleId><ArticleId IdType="pmc">PMC7818251</ArticleId><ArticleId IdType="pubmed">31957062</ArticleId></ArticleIdList></Reference><Reference><Citation>Perego MGL, Taiana M, Bresolin N, Comi GP, Corti S. R-loops in motor neuron diseases. Mol Neurobiol. 2019;56:2579&#x2013;2589. doi: 10.1007/s12035-018-1246-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1246-y</ArticleId><ArticleId IdType="pubmed">30047099</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Scotter EL, Nishimura AL, Troakes C, Mitchell JC, Kathe C, Urwin H, Manser C, Miller CC, Hortobagyi T, Dragunow M, Rogelj B, Shaw CE. ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules. Hum Mol Genet. 2013;22:2676&#x2013;2688. doi: 10.1093/hmg/ddt117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt117</ArticleId><ArticleId IdType="pmc">PMC3674807</ArticleId><ArticleId IdType="pubmed">23474818</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Langenhove T, van der Zee J, Sleegers K, Engelborghs S, Vandenberghe R, Gijselinck I, Van den Broeck M, Mattheijssens M, Peeters K, De Deyn PP, Cruts M, Van BC. Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology. 2010;74:366&#x2013;371. doi: 10.1212/WNL.0b013e3181ccc732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181ccc732</ArticleId><ArticleId IdType="pubmed">20124201</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejesus-Hernandez M, Kocerha J, Finch N, Crook R, Baker M, Desaro P, Johnston A, Rutherford N, Wojtas A, Kennelly K, Wszolek ZK, Graff-Radford N, Boylan K, Rademakers R. De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis. Hum Mutat. 2010;31:E1377&#x2013;E1389. doi: 10.1002/humu.21241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.21241</ArticleId><ArticleId IdType="pmc">PMC2922682</ArticleId><ArticleId IdType="pubmed">20232451</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Cruz S, Cleveland DW. Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr Opin Neurobiol. 2011;21:904&#x2013;919. doi: 10.1016/j.conb.2011.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2011.05.029</ArticleId><ArticleId IdType="pmc">PMC3228892</ArticleId><ArticleId IdType="pubmed">21813273</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T, Qamar S, Lin JQ, Schierle GS, Rees E, Miyashita A, Costa AR, Dodd RB, Chan FT, Michel CH, Kronenberg-Versteeg D, Li Y, Yang SP, Wakutani Y, Meadows W, Ferry RR, Dong L, Tartaglia GG, Favrin G, Lin WL, Dickson DW, Zhen M, Ron D, Schmitt-Ulms G, Fraser PE, Shneider NA, Holt C, Vendruscolo M, Kaminski CF, St George-Hyslop P. ALS/FTD Mutation-induced phase transition of FUS liquid droplets and reversible hydrogels into irreversible hydrogels impairs RNP granule function. Neuron. 2015;88:678&#x2013;690. doi: 10.1016/j.neuron.2015.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.030</ArticleId><ArticleId IdType="pmc">PMC4660210</ArticleId><ArticleId IdType="pubmed">26526393</ArticleId></ArticleIdList></Reference><Reference><Citation>Murthy AC, Dignon GL, Kan Y, Zerze GH, Parekh SH, Mittal J, Fawzi NL. Molecular interactions underlying liquid&#x2013;liquid phase separation of the FUS low-complexity domain. Nat Struct Mol Biol. 2019;26:637&#x2013;648. doi: 10.1038/s41594-019-0250-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-019-0250-x</ArticleId><ArticleId IdType="pmc">PMC6613800</ArticleId><ArticleId IdType="pubmed">31270472</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, Lee HO, Jawerth L, Maharana S, Jahnel M, Hein MY, Stoynov S, Mahamid J, Saha S, Franzmann TM, Pozniakovski A, Poser I, Maghelli N, Royer LA, Weigert M, Myers EW, Grill S, Drechsel D, Hyman AA, Alberti S. A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell. 2015;162:1066&#x2013;1077. doi: 10.1016/j.cell.2015.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D, Haass C. TDP-43 and FUS: a nuclear affair. Trends Neurosci. 2011;34:339&#x2013;348. doi: 10.1016/j.tins.2011.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2011.05.002</ArticleId><ArticleId IdType="pubmed">21700347</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T, Yang SP, Xie L, Kawano T, Fu D, Mukai A, Bohm C, Chen F, Robertson J, Suzuki H, Tartaglia GG, Vendruscolo M, Kaminski Schierle GS, Chan FT, Moloney A, Crowther D, Kaminski CF, Zhen M, St George-Hyslop P. ALS mutations in FUS cause neuronal dysfunction and death in Caenorhabditis elegans by a dominant gain-of-function mechanism. Hum Mol Genet. 2012;21:1&#x2013;9. doi: 10.1093/hmg/ddr417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr417</ArticleId><ArticleId IdType="pmc">PMC3235006</ArticleId><ArticleId IdType="pubmed">21949354</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JC, McGoldrick P, Vance C, Hortobagyi T, Sreedharan J, Rogelj B, Tudor EL, Smith BN, Klasen C, Miller CC, Cooper JD, Greensmith L, Shaw CE. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol. 2013;125:273&#x2013;288. doi: 10.1007/s00401-012-1043-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1043-z</ArticleId><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher DZ, Chaudhary N, Blobel G. cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins. Proc Natl Acad Sci USA. 1986;83:6450&#x2013;6454. doi: 10.1073/pnas.83.17.6450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.83.17.6450</ArticleId><ArticleId IdType="pmc">PMC386521</ArticleId><ArticleId IdType="pubmed">3462705</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin F, Worman HJ. Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J Biol Chem. 1993;268:16321&#x2013;16326. doi: 10.1016/S0021-9258(19)85424-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)85424-8</ArticleId><ArticleId IdType="pubmed">8344919</ArticleId></ArticleIdList></Reference><Reference><Citation>Machiels BM, Zorenc AH, Endert JM, Kuijpers HJ, van Eys GJ, Ramaekers FC, Broers JL. An alternative splicing product of the lamin A/C gene lacks exon 10. J Biol Chem. 1996;271:9249&#x2013;9253. doi: 10.1074/jbc.271.16.9249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.16.9249</ArticleId><ArticleId IdType="pubmed">8621584</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeon FD, Kirschner MW, Caput D. Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins. Nature. 1986;319:463&#x2013;468. doi: 10.1038/319463a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/319463a0</ArticleId><ArticleId IdType="pubmed">3453101</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa K, Inagaki H, Hotta Y. Identification and cloning of an mRNA coding for a germ cell-specific A-type lamin in mice. Exp Cell Res. 1994;212:426&#x2013;430. doi: 10.1006/excr.1994.1164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/excr.1994.1164</ArticleId><ArticleId IdType="pubmed">8187835</ArticleId></ArticleIdList></Reference><Reference><Citation>Bokenkamp R, Raz V, Venema A, DeRuiter MC, van Munsteren C, Olive M, Nabel EG, Gittenberger-de Groot AC. Differential temporal and spatial progerin expression during closure of the ductus arteriosus in neonates. PLoS ONE. 2011;6:e23975. doi: 10.1371/journal.pone.0023975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023975</ArticleId><ArticleId IdType="pmc">PMC3167818</ArticleId><ArticleId IdType="pubmed">21915271</ArticleId></ArticleIdList></Reference><Reference><Citation>Dittmer TA, Misteli T. The lamin protein family. Genome Biol. 2011;12:222. doi: 10.1186/gb-2011-12-5-222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2011-12-5-222</ArticleId><ArticleId IdType="pmc">PMC3219962</ArticleId><ArticleId IdType="pubmed">21639948</ArticleId></ArticleIdList></Reference><Reference><Citation>Dechat T, Pfleghaar K, Sengupta K, Shimi T, Shumaker DK, Solimando L, Goldman RD. Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev. 2008;22:832&#x2013;853. doi: 10.1101/gad.1652708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1652708</ArticleId><ArticleId IdType="pmc">PMC2732390</ArticleId><ArticleId IdType="pubmed">18381888</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon DN, Wilson KL. Partners and post-translational modifications of nuclear lamins. Chromosoma. 2013;122:13&#x2013;31. doi: 10.1007/s00412-013-0399-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00412-013-0399-8</ArticleId><ArticleId IdType="pmc">PMC3619935</ArticleId><ArticleId IdType="pubmed">23475188</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharner J, Lu HC, Fraternali F, Ellis JA, Zammit PS. Mapping disease-related missense mutations in the immunoglobulin-like fold domain of lamin A/C reveals novel genotype&#x2013;phenotype associations for laminopathies. Proteins. 2014;82:904&#x2013;915. doi: 10.1002/prot.24465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.24465</ArticleId><ArticleId IdType="pubmed">24375749</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C, Khalil B, Smith CL, Rossoll W. Traffic jam at the nuclear pore: all roads lead to nucleocytoplasmic transport defects in ALS/FTD. Neurobiol Dis. 2020;140:104835. doi: 10.1016/j.nbd.2020.104835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104835</ArticleId><ArticleId IdType="pmc">PMC7253339</ArticleId><ArticleId IdType="pubmed">32179176</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial &#x201c;Clinical limits of amyotrophic lateral sclerosis&#x201d; workshop contributors. J Neurol Sci 124 (Suppl):96&#x2013;107. 10.1016/0022-510x(94)90191-0</Citation><ArticleIdList><ArticleId IdType="pubmed">7807156</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, Mills K, Mitsumoto H, Nodera H, Shefner J, Swash M. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119:497&#x2013;503. doi: 10.1016/j.clinph.2007.09.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.09.143</ArticleId><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Boekestein WA, Kleine BU, Hageman G, Schelhaas HJ, Zwarts MJ. Sensitivity and specificity of the &#x2018;Awaji&#x2019; electrodiagnostic criteria for amyotrophic lateral sclerosis: retrospective comparison of the Awaji and revised El Escorial criteria for ALS. Amyotroph Lateral Scler. 2010;11:497&#x2013;501. doi: 10.3109/17482961003777462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482961003777462</ArticleId><ArticleId IdType="pubmed">20536375</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao H, Hegele RA. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet. 2000;9:109&#x2013;112. doi: 10.1093/hmg/9.1.109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/9.1.109</ArticleId><ArticleId IdType="pubmed">10587585</ArticleId></ArticleIdList></Reference><Reference><Citation>Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O'Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP, Kosmicki JA, Duncan LE, Estrada K, Zhao F, Zou J, Pierce-Hoffman E, Berghout J, Cooper DN, Deflaux N, DePristo M, Do R, Flannick J, Fromer M, Gauthier L, Goldstein J, Gupta N, Howrigan D, Kiezun A, Kurki MI, Moonshine AL, Natarajan P, Orozco L, Peloso GM, Poplin R, Rivas MA, Ruano-Rubio V, Rose SA, Ruderfer DM, Shakir K, Stenson PD, Stevens C, Thomas BP, Tiao G, Tusie-Luna MT, Weisburd B, Won HH, Yu D, Altshuler DM, Ardissino D, Boehnke M, Danesh J, Donnelly S, Elosua R, Florez JC, Gabriel SB, Getz G, Glatt SJ, Hultman CM, Kathiresan S, Laakso M, McCarroll S, McCarthy MI, McGovern D, McPherson R, Neale BM, Palotie A, Purcell SM, Saleheen D, Scharf JM, Sklar P, Sullivan PF, Tuomilehto J, Tsuang MT, Watkins HC, Wilson JG, Daly MJ, MacArthur DG. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285&#x2013;291. doi: 10.1038/nature19057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature19057</ArticleId><ArticleId IdType="pmc">PMC5018207</ArticleId><ArticleId IdType="pubmed">27535533</ArticleId></ArticleIdList></Reference><Reference><Citation>Karczewski KJ, Francioli L, Tiao G, Cummings BB, Alfoldi J, Wang Q, Collins R, Laricchia K, Ganna A, Bimbaum DP, Gauthier LD, Brand H, Solomonson M, Watts NA, Rhodes D, Singer-Berk M, Seaby EG, Kosmicki JA, Walters RK, Tashman K, Farjoun Y, Banks E, Poterba T, Wang A, Seed C, Whiffin N, Chong JX, Samocha KE, Pierce-Hoffman E, Zappala Z, O&#x2019;Donnell-Luria AH, Minikel EV, Weisburd B, Lek M, Ware JS, Vittal C, Armean IM, Bergelson L, Cibulskis K, Connolly KM, Covarrubias M, Donnelly S, Ferriera S, Gabriel S, Gentry J, Gupta N, Jeandet T, Kaplan D, Llanwarne C, Munshi R, Novod S, Petrillo N, Roazen D, Ruano-Rubio V, Saltzman A, Schleicher M, Soto J, Tibbetts RS, Tolonen C, Wade G, Talkowski ME (2019) Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. bioRxiv 10.1101/531210</Citation></Reference><Reference><Citation>Farhan SMK, Dilliott AA, Ghani M, Sato C, Liang E, Zhang M, McIntyre AD, Cao H, Racacho L, Robinson JF, Strong MJ, Masellis M, St George-Hyslop P, Bulman DE, Rogaeva E, Hegele RA. The ONDRISeq panel: custom-designed next-generation sequencing of genes related to neurodegeneration. NPJ Genomic Med. 2016;1:16032. doi: 10.1038/npjgenmed.2016.32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npjgenmed.2016.32</ArticleId><ArticleId IdType="pmc">PMC5685311</ArticleId><ArticleId IdType="pubmed">29263818</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, Hussain M, Phillips AD, Cooper DN. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet. 2017;136:665&#x2013;677. doi: 10.1007/s00439-017-1779-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-017-1779-6</ArticleId><ArticleId IdType="pmc">PMC5429360</ArticleId><ArticleId IdType="pubmed">28349240</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet. 2014;133:1&#x2013;9. doi: 10.1007/s00439-013-1358-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-013-1358-4</ArticleId><ArticleId IdType="pmc">PMC3898141</ArticleId><ArticleId IdType="pubmed">24077912</ArticleId></ArticleIdList></Reference><Reference><Citation>Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, Hoover J, Jang W, Katz K, Ovetsky M, Riley G, Sethi A, Tully R, Villamarin-Salomon R, Rubinstein W, Maglott DR. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2016;44:D862&#x2013;D868. doi: 10.1093/nar/gkv1222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv1222</ArticleId><ArticleId IdType="pmc">PMC4702865</ArticleId><ArticleId IdType="pubmed">26582918</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhan SMK, Howrigan DP, Abbott LE, Klim JR, Topp SD, Byrnes AE, Churchhouse C, Phatnani H, Smith BN, Rampersaud E, Wu G, Wuu J, Shatunov A, Iacoangeli A, Al KA, Mordes DA, Ghosh S, Eggan K, Rademakers R, McCauley JL, Schule R, Zuchner S, Benatar M, Taylor JP, Nalls M, Gotkine M, Shaw PJ, Morrison KE, Al-Chalabi A, Traynor B, Shaw CE, Goldstein DB, Harms MB, Daly MJ, Neale BM. Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein. Nat Neurosci. 2019;22:1966&#x2013;1974. doi: 10.1038/s41593-019-0530-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0530-0</ArticleId><ArticleId IdType="pmc">PMC6919277</ArticleId><ArticleId IdType="pubmed">31768050</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Spek RAA, van Rheenen W, Pulit SL, Kenna KP, van den Berg LH, Veldink JH, On Behalf of the Project MinE ALS Sequencing Consortium The project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:432&#x2013;440. doi: 10.1080/21678421.2019.1606244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1606244</ArticleId><ArticleId IdType="pmc">PMC7893599</ArticleId><ArticleId IdType="pubmed">31280677</ArticleId></ArticleIdList></Reference><Reference><Citation>Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. 2013 doi: 10.1002/0471142905.hg0720s76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471142905.hg0720s76</ArticleId><ArticleId IdType="pmc">PMC4480630</ArticleId><ArticleId IdType="pubmed">23315928</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073&#x2013;1081. doi: 10.1038/nprot.2009.86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2009.86</ArticleId><ArticleId IdType="pubmed">19561590</ArticleId></ArticleIdList></Reference><Reference><Citation>Kircher M, Witten DM, Jain P, O&#x2019;Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310&#x2013;315. doi: 10.1038/ng.2892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2892</ArticleId><ArticleId IdType="pmc">PMC3992975</ArticleId><ArticleId IdType="pubmed">24487276</ArticleId></ArticleIdList></Reference><Reference><Citation>Samocha KE, Kosmicki JA, Karczewski KJ, O&#x2019;Donnell-Luria AH, Pierce-Hoffman E, MacArthur DG, Neale BM, Daly MJ (2017) Regional missense constraint improves variant deleteriousness prediction. bioRxiv 10.1101/148353</Citation></Reference><Reference><Citation>Cohen S, Puget N, Lin YL, Clouaire T, Aguirrebengoa M, Rocher V, Pasero P, Canitrot Y, Legube G. Senataxin resolves RNA:DNA hybrids forming at DNA double-strand breaks to prevent translocations. Nat Commun. 2018;9:533. doi: 10.1038/s41467-018-02894-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-02894-w</ArticleId><ArticleId IdType="pmc">PMC5803260</ArticleId><ArticleId IdType="pubmed">29416069</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristini A, Groh M, Kristiansen MS, Gromak N. RNA/DNA hybrid interactome identifies DXH9 as a molecular player in transcriptional termination and R-loop-associated DNA damage. Cell Rep. 2018;23:1891&#x2013;1905. doi: 10.1016/j.celrep.2018.04.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.04.025</ArticleId><ArticleId IdType="pmc">PMC5976580</ArticleId><ArticleId IdType="pubmed">29742442</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Zhu M, Limbo O, Russell P. RNase H eliminates R-loops that disrupt DNA replication but is nonessential for efficient DSB repair. EMBO Rep. 2018;19:e45335. doi: 10.15252/embr.201745335.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201745335</ArticleId><ArticleId IdType="pmc">PMC5934767</ArticleId><ArticleId IdType="pubmed">29622660</ArticleId></ArticleIdList></Reference><Reference><Citation>Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res. 2003;31:3568&#x2013;3571. doi: 10.1093/nar/gkg616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkg616</ArticleId><ArticleId IdType="pmc">PMC169022</ArticleId><ArticleId IdType="pubmed">12824367</ArticleId></ArticleIdList></Reference><Reference><Citation>Cartegni L, Krainer AR. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet. 2002;30:377&#x2013;384. doi: 10.1038/ng854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng854</ArticleId><ArticleId IdType="pubmed">11925564</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimi T, Pfleghaar K, Kojima S, Pack CG, Solovei I, Goldman AE, Adam SA, Shumaker DK, Kinjo M, Cremer T, Goldman RD. The A- and B-type nuclear lamin networks: microdomains involved in chromatin organization and transcription. Genes Dev. 2008;22:3409&#x2013;3421. doi: 10.1101/gad.1735208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1735208</ArticleId><ArticleId IdType="pmc">PMC2607069</ArticleId><ArticleId IdType="pubmed">19141474</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke B, Stewart CL. The laminopathies: the functional architecture of the nucleus and its contribution to disease. Annu Rev Genomics Hum Genet. 2006;7:369&#x2013;405. doi: 10.1146/annurev.genom.7.080505.115732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.genom.7.080505.115732</ArticleId><ArticleId IdType="pubmed">16824021</ArticleId></ArticleIdList></Reference><Reference><Citation>Barateau A, Vadrot N, Vicart P, Ferreiro A, Mayer M, Heron D, Vigouroux C, Buendia B. A novel lamin A mutant responsible for congenital muscular dystrophy causes distinct abnormalities of the cell nucleus. PLoS ONE. 2017;12:e0169189. doi: 10.1371/journal.pone.0169189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0169189</ArticleId><ArticleId IdType="pmc">PMC5268432</ArticleId><ArticleId IdType="pubmed">28125586</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinszner H, Sok J, Immanuel D, Yin Y, Ron D. TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J Cell Sci. 1997;110:1741&#x2013;1750. doi: 10.1242/jcs.110.15.1741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.110.15.1741</ArticleId><ArticleId IdType="pubmed">9264461</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill SJ, Mordes DA, Cameron LA, Neuberg DS, Landini S, Eggan K, Livingston DM. Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage. Proc Natl Acad Sci USA. 2016;113:E7701&#x2013;E7709. doi: 10.1073/pnas.1611673113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1611673113</ArticleId><ArticleId IdType="pmc">PMC5137757</ArticleId><ArticleId IdType="pubmed">27849576</ArticleId></ArticleIdList></Reference><Reference><Citation>Becherel OJ, Yeo AJ, Stellati A, Heng EY, Luff J, Suraweera AM, Woods R, Fleming J, Carrie D, McKinney K, Xu X, Deng C, Lavin MF. Senataxin plays an essential role with DNA damage response proteins in meiotic recombination and gene silencing. PLoS Genet. 2013;9:e1003435. doi: 10.1371/journal.pgen.1003435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1003435</ArticleId><ArticleId IdType="pmc">PMC3623790</ArticleId><ArticleId IdType="pubmed">23593030</ArticleId></ArticleIdList></Reference><Reference><Citation>de Amicis A, Piane M, Ferrari F, Fanciulli M, Delia D, Chessa L. Role of senataxin in DNA damage and telomeric stability. DNA Repair (Amst) 2011;10:199&#x2013;209. doi: 10.1016/j.dnarep.2010.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2010.10.012</ArticleId><ArticleId IdType="pubmed">21112256</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuce O, West SC. Senataxin, defective in the neurodegenerative disorder ataxia with oculomotor apraxia 2, lies at the interface of transcription and the DNA damage response. Mol Cell Biol. 2013;33:406&#x2013;417. doi: 10.1128/MCB.01195-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01195-12</ArticleId><ArticleId IdType="pmc">PMC3554130</ArticleId><ArticleId IdType="pubmed">23149945</ArticleId></ArticleIdList></Reference><Reference><Citation>Groh M, Albulescu LO, Cristini A, Gromak N. Senataxin: genome guardian at the interface of transcription and neurodegeneration. J Mol Biol. 2017;429:3181&#x2013;3195. doi: 10.1016/j.jmb.2016.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2016.10.021</ArticleId><ArticleId IdType="pubmed">27771483</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnik-Schoneborn S, Arning L, Epplen JT, Zerres K. SETX gene mutation in a family diagnosed autosomal dominant proximal spinal muscular atrophy. Neuromuscul Disord. 2012;22:258&#x2013;262. doi: 10.1016/j.nmd.2011.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2011.09.006</ArticleId><ArticleId IdType="pubmed">22088787</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnik-Schoneborn S, Botzenhart E, Eggermann T, Senderek J, Schoser BG, Schroder R, Wehnert M, Wirth B, Zerres K. Mutations of the LMNA gene can mimic autosomal dominant proximal spinal muscular atrophy. Neurogenetics. 2007;8:137&#x2013;142. doi: 10.1007/s10048-006-0070-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-006-0070-0</ArticleId><ArticleId IdType="pubmed">17136397</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhouche A, Birouk N, Azzedine H, Benomar A, Durosier G, Ente D, Muriel MP, Ruberg M, Slassi I, Yahyaoui M, Dubourg O, Ouazzani R, LeGuern E. Autosomal recessive axonal Charcot&#x2013;Marie-Tooth disease (ARCMT2): phenotype&#x2013;genotype correlations in 13 Moroccan families. Brain. 2007;130:1062&#x2013;1075. doi: 10.1093/brain/awm014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm014</ArticleId><ArticleId IdType="pubmed">17347251</ArticleId></ArticleIdList></Reference><Reference><Citation>De Sandre-Giovannoli A, Chaouch M, Kozlov S, Vallat JM, Tazir M, Kassouri N, Szepetowski P, Hammadouche T, Vandenberghe A, Stewart CL, Grid D, Levy N. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot&#x2013;Marie-Tooth disorder type 2) and mouse. Am J Hum Genet. 2002;70:726&#x2013;736. doi: 10.1086/339274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/339274</ArticleId><ArticleId IdType="pmc">PMC384949</ArticleId><ArticleId IdType="pubmed">11799477</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahl KN, Kahn SM, Wilson KL, Discher DE. The nuclear envelope lamina network has elasticity and a compressibility limit suggestive of a molecular shock absorber. J Cell Sci. 2004;117:4779&#x2013;4786. doi: 10.1242/jcs.01357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.01357</ArticleId><ArticleId IdType="pubmed">15331638</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahl KN, Scaffidi P, Islam MF, Yodh AG, Wilson KL, Misteli T. Distinct structural and mechanical properties of the nuclear lamina in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA. 2006;103:10271&#x2013;10276. doi: 10.1073/pnas.0601058103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0601058103</ArticleId><ArticleId IdType="pmc">PMC1502447</ArticleId><ArticleId IdType="pubmed">16801550</ArticleId></ArticleIdList></Reference><Reference><Citation>Lammerding J, Lee RT. The nuclear membrane and mechanotransduction: impaired nuclear mechanics and mechanotransduction in lamin A/C deficient cells. Novartis Found Symp. 2005;264:264&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pubmed">15773759</ArticleId></ArticleIdList></Reference><Reference><Citation>Lammerding J, Fong LG, Ji JY, Reue K, Stewart CL, Young SG, Lee RT. Lamins A and C but not lamin B1 regulate nuclear mechanics. J Biol Chem. 2006;281:25768&#x2013;25780. doi: 10.1074/jbc.M513511200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M513511200</ArticleId><ArticleId IdType="pubmed">16825190</ArticleId></ArticleIdList></Reference><Reference><Citation>Favreau C, Higuet D, Courvalin JC, Buendia B. Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts. Mol Cell Biol. 2004;24:1481&#x2013;1492. doi: 10.1128/mcb.24.4.1481-1492.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.24.4.1481-1492.2004</ArticleId><ArticleId IdType="pmc">PMC344177</ArticleId><ArticleId IdType="pubmed">14749366</ArticleId></ArticleIdList></Reference><Reference><Citation>Favreau C, Dubosclard E, Ostlund C, Vigouroux C, Capeau J, Wehnert M, Higuet D, Worman HJ, Courvalin JC, Buendia B. Expression of lamin A mutated in the carboxyl-terminal tail generates an aberrant nuclear phenotype similar to that observed in cells from patients with Dunnigan-type partial lipodystrophy and Emery-Dreifuss muscular dystrophy. Exp Cell Res. 2003;282:14&#x2013;23. doi: 10.1006/excr.2002.5669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/excr.2002.5669</ArticleId><ArticleId IdType="pubmed">12490190</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang WY, Pan L, Su SC, Quinn EJ, Sasaki M, Jimenez JC, Mackenzie IR, Huang EJ, Tsai LH. Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. Nat Neurosci. 2013;16:1383&#x2013;1391. doi: 10.1038/nn.3514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3514</ArticleId><ArticleId IdType="pmc">PMC5564396</ArticleId><ArticleId IdType="pubmed">24036913</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>